Critical Path Institute

Critical Path Institute
Founded2005
Legal status501(c)(3) nonprofit organization
ServicesImprovement of the drug development process.
CEO
Klaus Romero[1]
Websitec-path.org

Critical Path Institute (C-Path) is a non-profit organization created to improve the drug development process; its consortia include more than 1,600 scientists from government regulatory and research agencies, academia, patient organizations, and bio-pharmaceutical companies.[2][3][4][5]

  1. ^ "Annual report 2023" (PDF). C-Path. Retrieved 31 January 2024.
  2. ^ Woosley, R. L. "The FDA’s Critical Path Initiative." Archived 2010-10-26 at the Wayback Machine PharmacoVigilance Review 1.3 (August 2007): 16-18
  3. ^ U.S. Food and Drug Administration. The Critical Path Initiative: Transforming the Way FDA-Regulated Products are Developed, Evaluated, Manufactured, and Used April 2009
  4. ^ FDA: Paving the Pathway for Innovation Archived 2011-06-11 at the Wayback Machine
  5. ^ Woodcock, J; Woosley, R (2008). "The FDA critical path initiative and its influence on new drug development". Annual Review of Medicine. 59: 1–12. doi:10.1146/annurev.med.59.090506.155819. PMID 18186700.